Abstract
The role of germline BRCA1 mutations in hereditary breast and ovarian cancer (HBOC) has been well established in women in Western countries. However, relatively few studies have been carried out in Chinese population. In the present study, we investigated the frequency and spectrum of germline BRCA1 mutations in Chinese HBOC patients, all of whom were from northern part of China. A total of 25 women with HBOC and ten relatives were analyzed. Mutation screening was performed by a combination of denaturing high-performance liquid chromatography and sequencing. Seven protein-truncating mutations were identified. They were 667delG, 3347A --> T, 3478del5, 4255delCT, 1235A --> G, 2064G --> T, and 5589del8. The first four of the mutations were putative ones never reported before. The prevalence of the protein-truncating mutations in this HBOC series was 40.0%, which is similar to that observed in Western hereditary ovarian cancer patients but higher than that reported in Chinese women with sporadic breast and ovarian cancer. Among the ten relatives we analyzed, six shared the same mutations with their affected relatives. No ovarian cancer was detected after 19 months of follow-up. This study showed that BRCA1 mutations play an importa...Continue Reading
References
Oct 9, 1982·Lancet·J K TobacmanJ F Fraumeni
Oct 7, 1994·Science·Y MikiW Ding
Dec 1, 1994·Nature Genetics·L H CastillaL C Brody
Dec 1, 1994·Nature Genetics·J SimardF Dion
Dec 1, 1994·Nature Genetics·L S FriedmanM C King
May 1, 1993·Cancer·M S PiverG Nava
Sep 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A DørumP Møller
Oct 23, 1997·JAMA : the Journal of the American Medical Association·D Shattuck-EidensA Thomas
Apr 17, 1998·JAMA : the Journal of the American Medical Association·F J Couch, L C Hartmann
May 14, 1999·Human Genetics·S S LiJ H Tsai
May 26, 1999·Journal of the National Cancer Institute·N L TangM Hjelm
Sep 1, 1999·Oncogene·U S KhooF C Ho
Feb 22, 2000·British Journal of Cancer·J H SngJ Wong
Mar 31, 2000·American Journal of Human Genetics·R MoslehiS A Narod
Jun 30, 2000·Human Mutation·U S KhooH Ozcelik
Jan 22, 2002·International Journal of Cancer. Journal International Du Cancer·A Meindl, UNKNOWN German Consortium for Hereditary Breast and Ovarian Cancer
Feb 22, 2002·Human Mutation·Ui-Soon KhooHilmi Ozcelik
Jun 20, 2003·Human Mutation·Zhen HuZhi-Ming Shao
Citations
Sep 14, 2007·Breast Cancer Research and Treatment·Wen-Feng LiZhi-Ming Shao
May 31, 2008·Breast Cancer Research and Treatment·Weiqiu ChenYuntao Xie
May 27, 2011·Breast Cancer Research and Treatment·Juan ZhangYuntao Xie
Jul 28, 2007·Familial Cancer·Ava KwongJ M Ford
Jan 16, 2013·Journal of Epidemiology·Wenming CaoJi-Cheng Li
Jul 10, 2016·Breast Cancer Research and Treatment·Juan ZhangYuntao Xie
Mar 16, 2017·International Journal of Cancer. Journal International Du Cancer·Guan-Tian LangZhi-Ming Shao
Jun 11, 2010·The HUGO Journal·Ava KwongD W West
Feb 16, 2018·Human Mutation·Timothy R RebbeckKatherine L Nathanson
Nov 24, 2012·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Wenming CaoJi-Cheng Li